Viyash Scientific · NSE: VIYASH · BSE: 512529
Q1 FY24 results · Apr–Jun 2023
Viyash Scientific reported revenue from operations of ₹333.21 crore (down 2.4% from Q1 FY23) and net loss of ₹34.68 crore for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 333.21 | 341.32 | −2.4% | 366.67 | −9.1% |
| Other income | 0.79 | 0.88 | −9.8% | 1.74 | −54.3% |
| Total income | 334.00 | 342.20 | −2.4% | 368.40 | −9.3% |
| Profit before tax | (55.68) | (19.57) | Loss widened | (88.80) | Loss narrowed |
| Net profit for the period | (34.68) | (14.41) | Loss widened | (92.44) | Loss narrowed |
| Attributable to shareholders of the company | (34.85) | (14.05) | Loss widened | (93.57) | Loss narrowed |
| EPS, basic (₹) | (1.40) | (0.57) | Loss widened | (3.77) | Loss narrowed |
| Net margin (%) | -10.4 | -4.2 | -25.2 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 40.42 | 64.86 | −37.7% | 46.59 | −13.2% |
| Other income | 9.70 | 5.88 | +64.9% | 8.01 | +21.0% |
| Total income | 50.12 | 70.74 | −29.2% | 54.61 | −8.2% |
| Profit before tax | (9.03) | 1.16 | Turned loss | (1.23) | Loss widened |
| Net profit for the period | (6.80) | 0.84 | Turned loss | (1.65) | Loss widened |
| EPS, basic (₹) | (0.27) | 0.03 | Turned loss | (0.07) | Loss widened |
| Net margin (%) | -16.8 | 1.3 | -3.5 |
Consolidated
- Filed with BSE
- 11 Aug 2023, 13:07 IST
- Board meeting
- 10 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Aug 2023, 13:07 IST
- Board meeting
- 10 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE